| アブストラクト | OBJECTIVES: To assess the association between COVID-19 booster vaccination and hospitalisation and/or death due to COVID-19 among adults with immune-mediated inflammatory diseases (IMIDs). METHODS: Adults with IMIDs prescribed steroid-sparing immune-suppressing drugs in Clinical Practice Research Datalink Aurum linked to hospitalisation and mortality records were included. Cases were hospitalised for or died due to COVID-19. Controls were risk-set matched to cases. Exposures were number of COVID-19 booster vaccinations between 16 September 2021 and 13 March 2023; receipt of autumn 2021, spring 2022, autumn 2022 boosters; and time since last booster. Multivariable logistic regression was used. Adjusted OR (aOR) and 95% CIs and adjusted vaccine effectiveness (1 - aORs x 100%) were calculated. RESULTS: We included 2178 cases and 17 750 controls (mean age 65.5 years; 60.2% women). Hospitalisation and/or death due to COVID-19 was negatively associated with receipt of three (aOR (95% CI) 0.20 (0.15 to 0.28)), two (aOR (95% CI) 0.29 (0.23 to 0.36)) or one booster (aOR (95% CI) 0.56 (0.48 to 0.65), respectively, compared with no booster. The aOR (95% CI) across the booster cycles were: autumn 2021 (aOR (95% CI) 0.40 (0.32 to 0.50)), spring 2022 (aOR (95% CI) 0.52 (0.42 to 0.65)) and autumn 2022 (aOR (95% CI) 0.33 (0.25 to 0.43)). Hospitalisation and/or death due to COVID-19 was negatively associated with booster vaccination within 365 days compared with no booster vaccination. There was no statistically significant association for boosters received more than 365 days ago. CONCLUSIONS: COVID-19 booster vaccination was associated with fewer hospitalisation and/or death due to COVID-19 among adults with IMIDs. These findings support regular booster vaccination in this high-risk population. |
|---|
| ジャーナル名 | RMD open |
|---|
| Pubmed追加日 | 2026/7/4 |
|---|
| 投稿者 | Kukreja, Niraj S; Nakafero, Georgina; Abhishek, Abhishek |
|---|
| 組織名 | University of Southampton, Southampton, UK.;Academic Rheumatology, City Hospital Nottingham, University of Nottingham,;Nottingham, UK georgina.nakafero@nottingham.ac.uk.;NIHR Nottingham Biomedical Research Centre, Nottingham, Nottinghamshire, UK.;Nottingham, UK. |
|---|
| Pubmed リンク | https://www.ncbi.nlm.nih.gov/pubmed/42399080/ |
|---|
